Cellceutix’s Drug Discovery Is a Major Leap Forward in the Fight Against Cancer
October 3, 2011 | Press Releases
Cellceutix to Pursue 505(b)(2) Clinical Process for Psoriasis Drug
September 26, 2011 | Press Releases
Cellceutix Signs Lab Services Research Support Agreement With Dana Farber/Partners CancerCare, Inc.
September 21, 2011 | Press Releases
With Contracts and IND Application in Hand, Cellceutix Nears Clinical Trials for New Cancer Drug
August 1, 2011 | Press Releases
Cellceutix Provides Updates on Kevetrin™, Cellceutix’s Novel Anti-Cancer Therapy
June 27, 2011 | Press Releases
Cellceutix’s Kevetrin™ Slows Pancreatic Cancer Tumor Growth by 94%; Protocol Towards Clinical Trials Nearing End
June 20, 2011 | Press Releases
Vendor Showcases Kevetrin™, Cellceutix’s Anti-Cancer Drug at American Society for Mass Spectrometry Meeting
June 6, 2011 | Press Releases
Cellceutix Announces Kevetrin™ in Combination With Radiation Delayed Tumor Growth by Twofold in Head and Neck Cancer Study
May 16, 2011 | Press Releases